N

Active Director Designated Partner DIN 10028406
DIN 10028406 First appointment Nov 2022 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Naeem

Data last updated:

Naeem is a Designated Partner at Rgrowmed Pharmaceuticals Llp (since 2022). The company operates in Paper.

DIN 10028406
Primary Designation Designated Partner
Industry Paper
First Appointment 15 Nov 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner15 Nov 20222022Active

Board colleagues of Naeem

NameDINCompanyDesignation
Rahul Sharma10028407Rgrowmed Pharmaceuticals LlpDesignated Partner
Shanu Sharma10028408Rgrowmed Pharmaceuticals LlpDesignated Partner
Sonu Kumar10083190Rgrowmed Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Rgrowmed Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Naeem

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naeem

Naeem currently holds 1 directorship: Rgrowmed Pharmaceuticals Llp (Designated Partner, since 15 Nov 2022).

Naeem was first appointed on 15 Nov 2022 as Designated Partner at Rgrowmed Pharmaceuticals Llp.

The current boards of Naeem's companies include Rahul Sharma (Rgrowmed Pharmaceuticals Llp), Shanu Sharma (Rgrowmed Pharmaceuticals Llp), Sonu Kumar (Rgrowmed Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available